effect-measures
| Topic | Replies | Views | Activity | |
|---|---|---|---|---|
|
Use of percentage change in clinical trials
|
|
16 | 608 | April 8, 2024 |
| Problems with NNT |
|
36 | 32962 | February 19, 2024 |
| Discussion of Assessing Heterogeneity of Treatment Effect, Estimating Patient-Specific Efficacy, and Studying Variation in Odds ratios, Risk Ratios, and Risk Differences |
|
33 | 11197 | June 16, 2023 |
| Is it legitimate to perform statistical test on test statistics such as t-values or z-scores? |
|
5 | 1393 | January 26, 2023 |
| Clarification on risk magnification |
|
7 | 3468 | May 9, 2022 |
| Calculating years of life lost due to COVID-19 |
|
3 | 3945 | June 10, 2021 |
| Calculating SMD from geometric mean titers |
|
2 | 4838 | May 26, 2021 |
| Odds ratios seem to be collapsible? |
|
17 | 7287 | February 25, 2021 |
| When to use absolute vs relative effect measures |
|
13 | 20480 | February 8, 2020 |
| Which SD to use when calculating standardised mean differences? |
|
1 | 3388 | October 2, 2019 |
|
Inequality of Variances in an RCT
|
|
12 | 8387 | December 27, 2018 |
| Absolute risk measures from count models |
|
6 | 7145 | October 24, 2018 |